References
- 1. NGUYEN G, MULLER DN. The biology of the (pro) renin receptor. J Am Soc Nephrol. 2010; 21(1):18-23.
- 2. SCHALEKAMP MA, DERKX FH, DEINUM J, DANSER AJ. Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors. J Hypertens. 2008; 26(5):928-937. Review.
- 3. VOLPE M, BATTISTONI A, CHIN D, RUBATTU S, TOCCI G. Renin as a biomarker of cardiovascular disease in clinical practice. Nutr Metab Cardiovasc Dis. 2012; 22 (4):312-317.
- 4. DICKSTEIN K, COHEN-SOLAL A, FILIPPATOS G, MCMURRAY JJ, PONIKOWSKI P, POOLE-WILSON PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J. 2008; 29:2388-2442.
- 5. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Technical Report Series 2000; 894: i-xii,1-253.
- 6. RUPERT JL, KIDD KK, NORMAN LE, MONSALVE MV, HOCHACHKA PW, DEVINE DV. Genetic polymorphisms in the renin-angiotensin system in high altitude and low altitude native American populations. Ann Hum Genet 2003; 67: 17-25.
- 7. PROCOPCIUC LM, CARACOSTEA G, ZAHARIE G, PUSCAS M, IORDACHE G, POPA M, et al. Maternal/newborn genotype contribution of the renin-angiotensin system [Met235Thr, Thr174Met, I/D-ACE, A2350G-ACE, A1166C-AT2R1, C3123A- AT2R2, 83A/G- REN] to the risk of pre-eclampsia: a Romanian study. J Renin Angiotensin Aldosterone Syst. 2011; 12(4):539-548.
- 8. McMURRAY JJ, ADAMOPOULOS S, ANKER SD, AURICCHIO A, BÖHM M, DICKSTEIN K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association [HFA] of the ESC. EHJ 2012:33; 1787-1847.
- 9. BRUNNER HR, LARAGH JH, BAER L, NEWTON MA, GOODWIN FT, KRAKOFF LR, et al. Essential hypertension: renin and aldosteron, heart attack and stroke. N Engl J Med 1972; 286: 441-449.
- 10. ALDERMAN MH, MADHAVAN S, OOI WL, COHEN H, SEALEY JE, LARAGH JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991; 324:1098-1104.
- 11. PARIKH NI, GONA P, LARSON MG, WANG TJ, NEWTON-CHEH C, LEVY D, et al. Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart Study. Eur Heart J 2007; 28:2644-2652.
- 12. POP DANA. Sistemul Renină-Angiotensină-Aldosteron în patogeneza bolilor cardiovasculare. Editura Clusium, Cluj-Napoca, 2007.
- 13. ALDI S, MARINO A, TOMITA K, CORTI F, ANAND R, OLSON KE, MARCUS AJ, LEVI R. E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role. FASEB J. 2014 Oct 15. pii: fj.14-261867.
- 14. SIM JJ, SHI J, AL-MOOMEN R, BEHAYAA H, KALANTAR-ZADEH K, JACOBSEN SJ. Plasma Renin activity and its association with ischemic heart disease, congestive heart failure, and cerebrovascular disease in a large hypertensive cohort. J Clin Hypertens (Greenwich). 2014; 16(11):805-813.
- 15. SEVER PS, CHANG CL, PRESCOTT MF, GUPTA A, POULTER NR, WHITEHOUSE A, SCANLON M. Is plasma rennin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Eur Heart J. 2012; 33(23):2970-2979.
- 16. BENEDICT CR, SHELTON B, JOHNSTONE DE, FRANCIS G, GREENBERG B, KONSTAM M, et al. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation 1996; 94:690-697.
- 17. VALDEZ-VELAZQUEZ LL, MENDOZA-CARRERA F, PEREZ-PARRA SA, RODARTE-HURTADO K, SANDOVALRAMIREZ L, MONTOYA-FUENTES H, et al. Renin gene haplotype diversity and linkage disequilibrium in two Mexican and one German population samples. J Renin Angiotensin Aldosteron Syst. 2011; 12(3):231-237.
- 18. SUN B, WILLIAMS JS, POJOGA L, CHAMARTHI B, LASKY-SU J, RABY BA, et al. Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses. J ReninAngiotensin Aldosterone Syst. 2011; 12 (4):564-571.
- 19. SCHLING P, LÖFFLER G. Effects of angiotensin II on adipose conversion and expression of genes of the renin-angiotensin system in human preadipocytes. Horm Metab Res. 2001; 33(4):189-95.
- 20. BARTON M, CARMONA R, ORTMANN J, KRIEGER JE, TRAUPE T. Obesity-associated activation of angiotensin and endothelin in the cardiovascular system. Int J Biochem Cell Biol. 2003; 35(6):826-837.
- 21. GEORGE BAKRIS. Are There Effects of Renin-Angiotensin System Antagonists Beyond Blood Pressure Control? American Journal of Cardiology. 2010; (105):21A-29A.
- 22. NISHIYAMA K, TSUTAMOTO T, KAWAHARA C, YAMAJI M, SAKAI H, YAMAMOTO T, et al. Relationship between biological variation in B-type natriuretic peptide and plasma rennin concentration in stable outpatients with dilated cardiomyopathy. Circ J. 2011; 75(8):1897-1904.
- 23. VREDEVOR DL, WOO MA, DOERING LV, BRECHT ML, HAMILTON MA, FONAROW GC. Skin test anergy in advanced chronic heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1998; 82: 323-328.
- 24. RAUCHHAUS M, KOLOCZEK V, HANS-DIETER V, KEMP M, NIEBAUER J, FRANCIS DP, et al. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol. 2000; 76: 125-133.
- 25. RAUCHHAUS M, COATS AJS, ANKER SD. The endotoxin-lipoprotein hypothesis. Lancet. 2000; 356: 930-933.
- 26. RAUCHHAUS M, CLARK AL, DOEHNER W, DAVOS C, BOLGER A, SHARMA R, et al. The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol.2003; 42:1933-1940.
- 27. WANG TJ, GONA P, LARSON MG, TOFLER GH, LEVY D, NEWTON-CHEH C, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355:2631-2639.